The Journal of International
Advanced Otology
Case Report

Intratympanic Gentamicin Injection for Endolymphatic Hydrops After Cochlear Implantation

1.

Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy

2.

Department of Otorhinolaryngology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

3.

Department of Otorhinolaryngology and Otoneurosurgery, University Hospital of Parma, Parma, Italy

J Int Adv Otol 2024; 20: 186-188
DOI: 10.5152/iao.2024.23122
Read: 106 Downloads: 64 Published: 29 March 2024

Endolymphatic hydrops has been documented as a possible complication of cochlear implantation; however, few studies have addressed its treatment. We describe the first case ever reported of delayed endolymphatic hydrops after a cochlear implant successfully treated with intratympanic gentamicin injection. A detailed discussion of this case with a focus on its management and outcomes will be provided in comparison with literature data. The intratympanic gentamicin injection has been demonstrated to be an effective treatment for symptomatic endolymphatic hydrops after cochlear implantation. We advocate further studies to validate this strategy as a promising alternative to surgical labyrinthectomy.

Cite this article as: Canzi P, Carlotto E, Quaglieri S, et  al. Intratympanic gentamicin injection for endolymphatic hydrops after cochlear implantation. J Int Adv Otol. 2024;20(2):186-188.

Files
EISSN 2148-3817